OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Bromodomain and BET family proteins as epigenetic targets in cancer therapy: their degradation, present drugs, and possible PROTACs
Mohd. Muddassir, Kunjal Soni, Chetan B. Sangani, et al.
RSC Advances (2020) Vol. 11, Iss. 2, pp. 612-636
Open Access | Times Cited: 12
Mohd. Muddassir, Kunjal Soni, Chetan B. Sangani, et al.
RSC Advances (2020) Vol. 11, Iss. 2, pp. 612-636
Open Access | Times Cited: 12
Showing 12 citing articles:
From triazolophthalazines to triazoloquinazolines: A bioisosterism-guided approach toward the identification of novel PCAF inhibitors with potential anticancer activity
Mohamed H. ElâShershaby, Adel Ghiaty, Ashraf H. Bayoumi, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 42, pp. 116266-116266
Closed Access | Times Cited: 65
Mohamed H. ElâShershaby, Adel Ghiaty, Ashraf H. Bayoumi, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 42, pp. 116266-116266
Closed Access | Times Cited: 65
Recent Advances on Small-Molecule Bromodomain-Containing Histone Acetyltransferase Inhibitors
Mingxia Liu, Kaiyao Zhang, Qinjue Li, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 3, pp. 1678-1699
Closed Access | Times Cited: 19
Mingxia Liu, Kaiyao Zhang, Qinjue Li, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 3, pp. 1678-1699
Closed Access | Times Cited: 19
PROTACs for BRDs proteins in cancer therapy: a review
Chao Wang, Yujing Zhang, Shanbo Yang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1694-1703
Open Access | Times Cited: 23
Chao Wang, Yujing Zhang, Shanbo Yang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1694-1703
Open Access | Times Cited: 23
Proteolysis targeting chimera of BI-2536 induces potent dual degradation of PLK1 and BET proteins
Shiwei Song, Wen Yang, Wanyi Tai
Bioorganic & Medicinal Chemistry (2025), pp. 118087-118087
Closed Access
Shiwei Song, Wen Yang, Wanyi Tai
Bioorganic & Medicinal Chemistry (2025), pp. 118087-118087
Closed Access
BRD1 deficiency affects SREBF1-related lipid metabolism through regulating H3K9ac/H3K9me3 transition to inhibit HCC progression
Mingyang Zhang, Jing Bai, Hailong Yuan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Mingyang Zhang, Jing Bai, Hailong Yuan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Bromodomain and extraterminal protein inhibitor JQ1 induces maturation arrest and disrupts the cytoplasmic organization in mouse oocytes under in vitro conditions
Keerthana Karunakar Poojary, Jyolsna Ponnaratta Kunhiraman, Vanishree Vasave Madhvacharya, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Keerthana Karunakar Poojary, Jyolsna Ponnaratta Kunhiraman, Vanishree Vasave Madhvacharya, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
A comprehensive review of BET-targeting PROTACs for cancer therapy
Xiaoli Zhou, Fang Zhao, Yong-Tao Xu, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 73, pp. 117033-117033
Closed Access | Times Cited: 17
Xiaoli Zhou, Fang Zhao, Yong-Tao Xu, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 73, pp. 117033-117033
Closed Access | Times Cited: 17
Development of versatile solid-phase methods for syntheses of PROTACs with diverse E3 ligands
Hanqiao Xu, Takashi Kurohara, Nobumichi Ohoka, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 86, pp. 117293-117293
Closed Access | Times Cited: 7
Hanqiao Xu, Takashi Kurohara, Nobumichi Ohoka, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 86, pp. 117293-117293
Closed Access | Times Cited: 7
Synthesis, SAR, and application of JQ1 analogs as PROTACs for cancer therapy
Soumik De, Raghaba Sahu, Shubhendu Palei, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117875-117875
Closed Access | Times Cited: 2
Soumik De, Raghaba Sahu, Shubhendu Palei, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117875-117875
Closed Access | Times Cited: 2
Design, synthesis, and biological evaluation of BRD4 degraders
Mengyuan Ding, Ying-Ying Shao, Danwen Sun, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 78, pp. 117134-117134
Closed Access | Times Cited: 11
Mengyuan Ding, Ying-Ying Shao, Danwen Sun, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 78, pp. 117134-117134
Closed Access | Times Cited: 11
A novel magnetic ligand-based assay for the electrochemical determination of BRD4
Simone Fortunati, Marco Giannetto, Federica Pedrini, et al.
Talanta (2024) Vol. 279, pp. 126577-126577
Open Access
Simone Fortunati, Marco Giannetto, Federica Pedrini, et al.
Talanta (2024) Vol. 279, pp. 126577-126577
Open Access
Mechanistic Insights into the Selective Dual BET and PLK1 Inhibitory Activity of a Novel Benzamide Compound in CastrationâResistant Prostrate Cancer
Oluwole B. Akawa, Temitayo I. Subair, Kehinde F. Omolabi, et al.
Chemistry & Biodiversity (2021) Vol. 18, Iss. 12
Closed Access | Times Cited: 1
Oluwole B. Akawa, Temitayo I. Subair, Kehinde F. Omolabi, et al.
Chemistry & Biodiversity (2021) Vol. 18, Iss. 12
Closed Access | Times Cited: 1
